Steve Elms Adma Biologics, Inc. (ADMA) insider trading activity

Steve Elms is of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 87,330 shares of ADMA, which is worth approximately $1.57 Million. The most recent transaction as insider was on Jun 16, 2025, when has been sold 194,749 shares (Common Stock) at a price of $20.24 per share, resulting in proceeds of $3,941,719. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.3K

0% 3M change

14.24% 12M change

Total Value Held $1.57 Million

STEVE ELMS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 16 2025	SELL Open market or private sale	$3,941,719 $20.24 p/Share	194,749 Reduced 69.04%	87,330 Common Stock
Jun 13 2025	SELL Open market or private sale	$2,871,723 $20.82 p/Share	137,931 Reduced 32.84%	282,079 Common Stock
Jun 13 2025	BUY Exercise of conversion of derivative security	$1,300,778 $3.91 p/Share	332,680 Added 44.2%	420,010 Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	10,889 Added 11.09%	87,330 Common Stock
Feb 26 2024	BUY Grant, award, or other acquisition	-	24,040 Added 23.92%	76,441 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	25,815 Added 33.0%	52,401 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	-	26,586 Added 50.0%	26,586 Common Stock

Also insider at

ELEV

Elevation Oncology, Inc. Healthcare

MRKR

Marker Therapeutics, Inc. Healthcare

Director

ZSANQ

Zosano Pharma Corp

Director

Steve Elms

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Value

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA

Account